Drug Safety Labeling Changes
The summary view includes drug products with safety labeling changes to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE sections. The “quick view” table below provides the drug name and sections modified. Click on the drug name to go to the detailed view. The detailed view includes sections and subsections modified, a description of new or modified safety information in the BOXED WARNING, CONTRAINDICATIONS, or WARNINGS sections, and a link to the revised prescribing information.
Key to Label Section Acronyms:
BW=BOXED WARNING, C=CONTRAINDICATIONS, W=WARNINGS, P=PRECAUTIONSAR=ADVERSE REACTIONS, PPI/MG=PATIENT PACKAGE INSERT/MEDICATION GUIDE
BW
C
W
P
AR
Codeine Sulfate Solution
* Risk of respiratory depression and death in children
Codeine Sulfate Tablets
Fioricet with Codeine (butalbital, acetaminophen, caffeine, and codeine phosphate) Capsules
Fiorinal with Codeine (butalbital, aspirin, caffeine, and codeine phosphate, USP) Capsules
Promethazine and Codeine Syrup
Promethazine, Phenylephrine and Codeine Syrup
Soma Compound with Codeine (carisoprodol, aspirin, and codeine phosphate) Tablets
SynalgosDC (dihydrocodeine bitartrate, aspirin and caffeine) Capsules
Metadate CD (methylphenidate HCl) Extended-Release Capsules 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, and 60 mg
Contact us to become a Sponsor